blogging-invest 
TechCrunch LA
OCTOBER 9, 2018
Those services — and the company’s growing business among small and medium-sized suppliers to the construction industry — brought the Austin-based company to the attention of Fifth Wall Ventures , the Los Angeles based investment firm whose limited partners are among the biggest construction companies in the world.
Startup Professionals Musings
OCTOBER 24, 2018
I’m talking about using the new digital channels of blogging, social media, and influencers more creatively to “pull” people to your solution, and make them advocates. Let me be clear – I’m not talking about the old-fashioned “push” marketing, where you broadcast your message louder and more incessantly than others to get above the din.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
OCTOBER 23, 2018
Ed Kaye stepped aside from Sarepta Therapeutics (NASDAQ: SRPT ) last year after leading the company through one of the most noteworthy and controversial drug approvals in recent memory, for the Duchenne muscular dystrophy drug eteplirsen (Exondys 51). But his hiatus from a publicly traded biotech could be short-lived.
Xconomy
OCTOBER 29, 2018
In September, Backstage Capital , a venture investment firm seeding early-stage startups led by women, people of color, and members of the LGBTQ community, launched a $36 million fund to help support black women founders.
Xconomy
OCTOBER 19, 2018
Five-year-old biotech TP Therapeutics has raised an $80 million mezzanine financing round and promoted its chief medical officer, Athena Countouriotis, to CEO. The San Diego-based biotech, which is developing targeted cancer drugs for people whose tumors resist other precision therapies, announced the changes Friday.
Xconomy
OCTOBER 15, 2018
More days than not, Michael Colaneri’s home is a hotel room. So innovations like “geolocation” sensors that automatically unlock his room door and adjust the thermostat when he’s nearby make the constant change easier—sometimes. “My My experience has been exceptionally inconsistent,” he says.
Xconomy
OCTOBER 1, 2018
VelosBio, a biotech startup researching new cancer drugs, has raised $58 million in financing. The new VelosBio cash, a Series A round of financing, was led by Arix Bioscience (LSE: ARIX ) and Sofinnova Ventures. VelosBio joined Johnson & Johnson’s JLABS @ San Diego incubator in January.
Expert insights. Personalized for you.
191 
Let's personalize your content